Peter Devilee
Peter Devilee
Leiden University Medical Center
Bestätigte E-Mail-Adresse bei
TitelZitiert vonJahr
Identification of the breast cancer susceptibility gene BRCA2
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, ...
Nature 378 (6559), 789-792, 1995
Pathology and genetics of tumours of the breast and female genital organs
JN Eble, FA Tavassoli, P Devilee
Iarc, 2003
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ...
The American Journal of Human Genetics 62 (3), 676-689, 1998
Mutations in the p53 gene occur in diverse human tumour types
JM Nigro, SJ Baker, AC Preisinger, JM Jessup, R Hosteller, K Cleary, ...
Nature 342 (6250), 705-708, 1989
Genome-wide association study identifies novel breast cancer susceptibility loci
DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ...
Nature 447 (7148), 1087-1093, 2007
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
R Wooster, SL Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, ...
Science 265 (5181), 2088-2090, 1994
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
BE Baysal, RE Ferrell, JE Willett-Brozick, EC Lawrence, D Myssiorek, ...
Science 287 (5454), 848-851, 2000
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
CHEK2-Breast Cancer Consortium
Nature genetics 31 (1), 55, 2002
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ...
Nature genetics 45 (4), 353, 2013
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
SR Lakhani, JS Reis-Filho, L Fulford, F Penault-Llorca, M van der Vijver, ...
Clinical cancer research 11 (14), 5175-5180, 2005
WHO classification of tumors. Tumors of the breast and female genital organs
FA Tavassoli
Lyon IRAC, 100-103, 2003
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
SR Lakhani, J Jacquemier, JP Sloane, BA Gusterson, TJ Anderson, ...
Journal of the National Cancer Institute 90 (15), 1138-1145, 1998
World Health Organization classification of tumors
FA Tavassoli
Pathology and genetics of tumors of the breast and female genital organs 97, 2003
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma
HX Hao, O Khalimonchuk, M Schraders, N Dephoure, JP Bayley, H Kunst, ...
Science 325 (5944), 1139-1142, 2009
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
XR Yang, J Chang-Claude, EL Goode, FJ Couch, H Nevanlinna, RL Milne, ...
Journal of the National Cancer Institute 103 (3), 250-263, 2011
In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors
AHN Hopman, FCS Ramaekers, AK Raap, JLM Beck, P Devilee, ...
Histochemistry 89 (4), 307-316, 1988
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
LC Verhoog, CTM Brekelmans, C Seynaeve, LMC Van den Bosch, ...
The Lancet 351 (9099), 316-321, 1998
Gene-panel sequencing and the prediction of breast-cancer risk
DF Easton, PDP Pharoah, AC Antoniou, M Tischkowitz, SV Tavtigian, ...
New England Journal of Medicine 372 (23), 2243-2257, 2015
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23. 2
S Ahmed, G Thomas, M Ghoussaini, CS Healey, MK Humphreys, R Platte, ...
Nature genetics 41 (5), 585, 2009
Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization …
T Cremer, J Landegent, A Brückner, HP Scholl, M Schardin, HD Hager, ...
Human genetics 74 (4), 346-352, 1986
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20